Canada markets closed

Guardion Health Sciences, Inc. (GHSI)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
7.90-0.23 (-2.83%)
At close: 04:00PM EDT

Guardion Health Sciences, Inc.

2925 Richmond Avenue
Suite 1200
Houston, TX 77098
United States
800 873 5141
https://www.guardionhealth.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees9

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert Neal WeingartenIndependent Chairman & Secretary79kN/A1952
Mr. Craig J. SheehanChief Commercial Officer256.88kN/A1971
Ms. Janet HallPresident & CEON/AN/A1959
Ms. Katie CoxChief Accounting OfficerN/AN/A1970
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Corporate Governance

Guardion Health Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.